Former Chief Executive Officer and Director (4) · Summit Therapeutics Inc. (SMMT)

Glyn Edwards

A named executive officer of Summit Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$621,822

Salary $137,855Stock awards $0Bonus $3,209

FY2019: $871,908

3rd of 5 named executive officers at Summit Therapeutics by FY2020 total.

6 named officers on file for Summit Therapeutics, FY2020

Glyn Edwards’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Summit Therapeutics’s whole pay program stands against its peers

  • Summit Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SMMT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A).

Free

Get Glyn Edwards’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Glyn Edwards compensation by year

Summit Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Summit Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$378,149$137,855
Bonus$2,552$3,209
Stock awards$0$0
Option awards$459,301$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$31,906$480,728
Total$871,908$621,822

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Therapeutics Inc. DEF 14A filed April 29, 2021, accession 0000921895-21-001172, and prior-year filings.

How this page was built: the Summit Therapeutics Inc. filed document, accession 0000921895-21-001172. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

$872K
$622K
FY19
FY20
SalaryBonusOption awardsAll other

Summit Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Michael DonaldsonChief Financial Officer$961,418
Ventzislav StefanovFormer Executive Vice President, President of Discuva and Director (4)$674,823
Glyn Edwards · this pageFormer Chief Executive Officer and Director (4)$621,822
Mahkam ZanganehDirector and Chief Operating Officer (3)$527,312
David PowellFormer Chief Scientific Officer$401,124
Robert DugganChief Executive Officer and Executive Chairman (2)—

The full Summit Therapeutics compensation record

free company brief

This page is one person within Summit Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Summit Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Glyn Edwards's compensation dossier · One-time report. No refunds.